Advanced Controlled Drug Delivery Platforms

Abstract

Controlled drug delivery platforms have moved well beyond simple sustained-release coatings into sophisticated engineered systems capable of targeting specific cell populations, responding to physiological triggers, and delivering macromolecular therapeutics -- proteins, nucleic acids, gene editors -- that conventional formulation approaches cannot handle. The diversity of platform technologies now available -- nanoparticles, hydrogel depots, microneedle patches, stimuli-responsive smart carriers, and exosome-based biological delivery vehicles -- has outpaced systematic comparative evidence on which platform performs best in which clinical context. This study presents the Advanced Drug Delivery Platform Assessment Framework (ADDPAF), evaluating five platform categories across four clinical contexts: oncology targeted delivery, chronic disease management, vaccine and immunotherapy delivery, and CNS drug delivery. Performance was scored using the Platform Effectiveness Score (PES), a weighted composite of drug targeting efficiency (0.30), controlled release precision (0.20), biocompatibility (0.20), manufacturing scalability (0.15), and clinical readiness (0.15). Nanoparticle-based platforms achieved the highest PES (0.897), driven by the best targeting efficiency (0.940) and strong clinical readiness (0.900), supported by the regulatory precedent established by lipid nanoparticle COVID-19 vaccines. Hydrogel depot systems ranked second (0.875) with the best controlled release precision (0.940). Microneedle patches scored third (0.860) with the highest biocompatibility (0.920) and the strongest performance in vaccine delivery contexts. Exosome-based platforms achieved the best biocompatibility of all categories (0.960) but were limited by manufacturing scalability (0.720) and clinical readiness (0.740), placing them fifth overall despite their biological delivery advantages for CNS applications where the blood-brain barrier presents a fundamental targeting challenge for synthetic platforms.